Merims S - Search Results

1

The validity of the Mathias criteria for establishing occupational causation and aggravation of contact dermatitis.

Ingber A, Merims S. Ingber A, et al. Among authors: merims s. Contact Dermatitis. 2004 Jul;51(1):9-12. doi: 10.1111/j.0105-1873.2004.00273.x. Contact Dermatitis. 2004. PMID: 15291825

2

Assessing Response to New Treatments and Prognosis in Melanoma Patients, by the Biomarker S-100β.

Barak V, Leibovici V, Peretz T, Kalichman I, Lotem M, Merims S. Barak V, et al. Among authors: merims s. Anticancer Res. 2015 Dec;35(12):6755-60. Anticancer Res. 2015. PMID: 26637892

3

Pityriasis rubra pilaris induced by PD-1 inhibitor nivolumab.

Goldberger T, Armoni G, Lavie D, Merims S, Maly A, Shreberk-Hassidim R. Goldberger T, et al. Among authors: merims s. Int J Dermatol. 2021 Aug;60(8):1038-1039. doi: 10.1111/ijd.15563. Epub 2021 Apr 12. Int J Dermatol. 2021. PMID: 33846975 No abstract available.

4

MHC class I-independent recognition of NK-activating receptor KIR2DS4.

Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G, Gruda R, Achdout H, Drize O, Merims S, Mandelboim O. Katz G, et al. Among authors: merims s. J Immunol. 2004 Aug 1;173(3):1819-25. doi: 10.4049/jimmunol.173.3.1819. J Immunol. 2004. PMID: 15265913

5

Trogocytosis is a gateway to characterize functional diversity in melanoma-specific CD8+ T cell clones.

Uzana R, Eisenberg G, Sagi Y, Frankenburg S, Merims S, Amariglio N, Yefenof E, Peretz T, Machlenkin A, Lotem M. Uzana R, et al. Among authors: merims s. J Immunol. 2012 Jan 15;188(2):632-40. doi: 10.4049/jimmunol.1101429. Epub 2011 Dec 7. J Immunol. 2012. PMID: 22156347

6

Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma.

Lotem M, Shiloni E, Pappo I, Drize O, Hamburger T, Weitzen R, Isacson R, Kaduri L, Merims S, Frankenburg S, Peretz T. Lotem M, et al. Among authors: merims s. Br J Cancer. 2004 Feb 23;90(4):773-80. doi: 10.1038/sj.bjc.6601563. Br J Cancer. 2004. PMID: 14970852 Free PMC article. Clinical Trial.

7

HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccine.

Lotem M, Kadouri L, Merims S, Ospovat I, Nissan A, Ron I, Frankenburg S, Machlenkin A, Israel S, Steinberg H, Hamburger T, Peretz T. Lotem M, et al. Among authors: merims s. Tissue Antigens. 2011 Sep;78(3):203-7. doi: 10.1111/j.1399-0039.2011.01709.x. Epub 2011 Jun 7. Tissue Antigens. 2011. PMID: 21644933

8

[Ctla-4 blockade: a new hope for the immunotherapy of malignant melanoma].

Lotem M, Merims S, Frank S, Ospovat I, Peretz T. Lotem M, et al. Among authors: merims s. Harefuah. 2012 Oct;151(10):585-8, 604. Harefuah. 2012. PMID: 23316667 Review. Hebrew.

9

Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cells.

Eisenberg G, Uzana R, Pato A, Frankenburg S, Merims S, Yefenof E, Ferrone S, Peretz T, Machlenkin A, Lotem M. Eisenberg G, et al. Among authors: merims s. J Immunol. 2013 Jun 1;190(11):5856-65. doi: 10.4049/jimmunol.1202879. Epub 2013 Apr 26. J Immunol. 2013. PMID: 23626012 Free PMC article.

10

Informal caregiving to older cancer patients: preliminary research outcomes and implications.

Goldzweig G, Merims S, Ganon R, Peretz T, Altman A, Baider L. Goldzweig G, et al. Among authors: merims s. Ann Oncol. 2013 Oct;24(10):2635-2640. doi: 10.1093/annonc/mdt250. Epub 2013 Jul 25. Ann Oncol. 2013. PMID: 23894037 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page